Kisspeptins Block Endometriosis Progression by Targeting Key Signaling Pathway

Endometriosis is a chronic and often debilitating condition characterized by the growth of endometrial-like tissue outside the uterus, leading to severe pelvic pain, infertility, and reduced quality of life. Current therapeutic options are often limited, invasive, or associated with significant side effects, highlighting an urgent need for novel treatments. This study specifically investigated how kisspeptins might offer a new therapeutic avenue by inhibiting the invasion and angiogenesis of ectopic endometrial cells through specific molecular pathways.

The study conclusively demonstrated that kisspeptins exerted a significant inhibitory effect on the invasion capabilities of ectopic endometrial cells, suggesting a direct impact on the spread of the disease. Furthermore, a substantial reduction in angiogenesis was observed, indicating that kisspeptins can hinder the formation of new blood vessels necessary for the growth and sustenance of endometrial lesions. > The most critical finding was that kisspeptins achieved these potent inhibitory effects by effectively suppressing the PI3K/AKT signaling pathway through the upregulation of CREB5. This suppression led to a marked decrease in cellular proliferation and migratory activity in treated cells compared to untreated control groups, highlighting a precise molecular mechanism. The findings suggest a strong correlation between kisspeptin treatment and the downregulation of pro-survival and pro-angiogenic signals.